NCT04983901 2024-11-04PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONINM.D. Anderson Cancer CenterPhase 2 Completed100 enrolled 38 charts
NCT00035425 2009-12-01Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive InfectionPfizerPhase 3 Completed120 enrolled